Enhancing prognostic accuracy in predicting rectal neuroendocrine neoplasms

doi:10.3748/wjg.v30.i37.4087

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (733)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

638

Sum=656

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=52

Oct 7, 2024 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Oct 7, 2024; 30(37): 4087-4089
Published online Oct 7, 2024. doi: 10.3748/wjg.v30.i37.4087

Enhancing prognostic accuracy in predicting rectal neuroendocrine neoplasms

Renin Peter AA Raj, Abdulqadir J Nashwan

Renin Peter AA Raj, Department of Medicine, Aston Medical School, Birmingham B4 7ET, United Kingdom

Abdulqadir J Nashwan, Department of Nursing & Midwifery Research, Hamad Medical Corporation, Doha 3050, Qatar

Author contributions: Raj RPA, Nashwan AJ contributed to writing the draft and critically reviewing the literature.

Conflict-of-interest statement: All the authors declare that they have no conflicts of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/

Corresponding author: Abdulqadir J Nashwan, MSc, PhD, Research Scientist, Department of Nursing & Midwifery Research, Hamad Medical Corporation, Rayyan Road, Doha 3050, Qatar. anashwan@hamad.qa

Received: August 4, 2024
Revised: August 19, 2024
Accepted: September 5, 2024
Published online: October 7, 2024
Processing time: 53 Days and 2.1 Hours

Core Tip

Core Tip: The GATIS score, developed from a 12-year study of 1408 patients with rectal neuroendocrine neoplasms (R-NENs) across 17 major Chinese centers, predicts overall survival and progression-free survival more accurately than World Health Organization grade and tumor-node-metastasis staging. This score offers improved personalized patient management and treatment planning. However, the study includes limitations such as short follow-up durations and exclusion of molecular and genetic factors. Addressing these in future research could further enhance treatment strategies for R-NENs.